Integra LifeSciences (NASDAQ: IART) and Tornier N.V. (Nasdaq: TRNX), announced a definitive agreement under which Integra will acquire the United States rights to Tornier’s Salto Talaris and Salto XT ankle replacement products and Tornier’s Futura silastic toe replacement products, for an undisclosed

Share on LinkedInShare on FacebookShare on Google+Pin on PinterestEmail this to someone